Numinus Chief Operating Officer Michael Tan explains what the company's recent Health Canada licence amendment, which will allow them to produce and extract psilocybin from mushrooms, means for upcoming research.
Menu
Numinus Chief Operating Officer Michael Tan explains what the company's recent Health Canada licence amendment, which will allow them to produce and extract psilocybin from mushrooms, means for upcoming research.
Would you like to be a guest on our podcast?
